Condition: Gastrointestinal Stromal Tumors · Small-cell Lung Cancer · Adenoid Cystic Carcinoma · Sponsor: Novelty Nobility, Inc.
This open-label clinical trial will evaluate the safety and tolerability of NN3201 in subjects with advanced and/or metastatic solid tumors known to express c-Kit.
This description comes directly from the study's public registry record.
Clinical Trial Lead · 1 617.870.7173 · NN3201@noveltynobility.com
Always discuss trial participation with your own doctor first.
| University of Michigan Hospitals | Ann Arbor, Michigan, United States | Recruiting |
| Case Comprehensive Cancer Center | Cleveland, Ohio, United States | Recruiting |
| Oregon Health & Science University | Portland, Oregon, United States | Recruiting |
| The University of Texas MD Anderson Cancer Center | Houston, Texas, United States | Recruiting |
| NEXT Virginia | Fairfax, Virginia, United States | Active Not Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06805825